Cover Image

The Role of Tumor Necrosis Factor  (TNF ) and Matrix Metalloproteinase9 (MMP9) Serum in Preterm Premature Rupture of Membranes

Objective: To investigate the role of TNF- and MMP-9 serum in preterm premature rupture of membranes (PPROM). Methods: We used cross-sectional study design. Subjects were all pregnant women with and without PPROM who underwent check up at Obstetrics and Gynecology Functional Medical Staff General H...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ardiles Ardiles (Author), Desmiwarti Desmiwarti (Author), Hafni Bachtiar (Author)
Format:	Book
Published:	Indonesian Society of Obstetrics and Gynecology, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Difference of Serum MMP9 and TNF 􀁃 Level in Preterm and Term Premature Rupture of Membranes
by: Aji P Wibowo, et al.
Published: (2015)

The Role of Matrix Metalloproteinase9 (MMP9) in Endometriosis
by: Amalia Amalia, et al.
Published: (2017)

The Difference of Zinc And Matrix Levels of Metalloproteinase-9 Serum Between Premature Rupture Of Membrane Aterm And Normal Pregnancy
by: Lisa Ernita, et al.
Published: (2019)

C-Reactive Protein and Matrix Metalloproteinase-7 in Preterm Premature Rupture of Membranes (PPROM) and Premature Rupture of Membranes (PROM)
by: Rajuddin Rajuddin, et al.
Published: (2022)

Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
by: Jennifer Orozco-Páez, et al.
Published: (2021)

Matrix Metalloproteinase-9 (<it>MMP-9</it>) polymorphisms in patients with cutaneous malignant melanoma
by: Busam Klaus, et al.
Published: (2007)

Estimation of Matrix Metalloproteinases-9 (MMP-9) Levels in Children with Early Childhood Caries
by: Ngangbam Reenayai, et al.
Published: (2022)

Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines
by: Yihe Wang, et al.
Published: (2022)

Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion
by: Gabarin Diana, et al.
Published: (2004)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
by: Noriko Kudo, et al.
Published: (2020)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015)

Matrix Metalloproteinases MMP-2 and MMP-9 Occupy a New Role in Severe Preeclampsia
by: Elena Timokhina, et al.
Published: (2020)

Human Host Defense Peptide LL-37 Suppresses TNFα-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells
by: Anthony Altieri, et al.
Published: (2024)

In vitro secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to <it>Escherichia coli</it>
by: Merchant-Larios Horacio, et al.
Published: (2011)

Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease
by: Lidia Ciccone, et al.
Published: (2021)

Assessment of Metalloproteinase Matrix 9 (MMP9) Gene Polymorphisms Risk Factors for Pelvic Organ Prolapse in the Brazilian Population
by: Frederico Rezende Ghersel, et al.

Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors
by: Amir Hossein Jafarian, et al.
Published: (2020)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
by: Rajendran R, et al.
Published: (2006)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
by: Nissi Ritva, et al.
Published: (2013)

The Role of Matrix Metalloproteinases (MMP-2 and MMP-9) in Ageing and Longevity: Focus on Sicilian Long-Living Individuals (LLIs)
by: Patrizia Cancemi, et al.
Published: (2020)

Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys
by: Youn Ho Shin, et al.
Published: (2014)

Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-α Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis
by: Takuya Kotani, et al.
Published: (2012)

Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients
by: Yu-Feng Hsiao, et al.
Published: (2016)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017)

Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis.
by: Taís M Campos, et al.
Published: (2014)

Use of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathomorphological diagnosis of carotid pathology: literature review and own observations
by: Yu. I. Kuzyk
Published: (2016)

Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
by: Flavia Morales-Vásquez, et al.
Published: (2020)

<it>Matrix metalloproteinase-9 </it>gene polymorphisms in nasal polyposis
by: Tai Chih-Feng, et al.
Published: (2010)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
by: Tiewei Li, et al.
Published: (2020)

THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY
by: S. V. Ziablitsev, et al.
Published: (2016)

THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY
by: S. V. Ziablitsev, et al.
Published: (2016)

Pregnancy outcomes in preterm premature rupture of the membranes
by: I.I. Tosheva, et al.
Published: (2020)

The Investigation of Caspase-3 and Tumor Necrosis Factor-Alpha Expression in Placentas of Patients with Preterm Premature Rupture of Membranes
by: Işılay Sezen Ermiş, et al.
Published: (2023)

Investigating salivary matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in fixed orthodontic-induced gingival enlargement
by: Narges Ziaei, et al.
Published: (2024)

Variants of the <it>Matrix Metalloproteinase-2 </it>but not the <it>Matrix Metalloproteinase-9 </it>genes significantly influence functional outcome after stroke
by: Sobral João, et al.
Published: (2010)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023)

Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.
by: Michal eStawarski, et al.
Published: (2014)

Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development
by: Elżbieta Bronisz, et al.
Published: (2016)

Comparison of the prevalence of Mycoplasm hominis infection in pregnant women with and without preterm premature rupture of membranes and the relationship of this infection with preterm premature rupture of membranes
by: Nooshin Mobaraki, et al.
Published: (2019)

Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation
by: Bitan Naik, et al.
Published: (2016)